DECEMBER 2024 NEWSLETTER

As we wind down 2024, we reflect on our shared accomplishments while never losing sight of our critical and life-saving mission. At the same time, we look forward to an exciting and impactful year ahead, especially as ICRF celebrates its 50th anniversary in 2025.


In our 50th year we are positioned to surpass $100 million of funding invested in grants to Israel's most promising scientists. Together, at this pivotal moment marking 50 years of impact, we'll reflect on the past, celebrate our present achievements, and further solidify the promising future that we're determined to create -- a cancer-free world. More details about ICRF@50 will be shared soon.

Scientific Grant Funding Update

Our scientists experienced unimaginable challenges this year. Through it all, they persevered, just as Israel does time and again in the face of adversity. They won't let anything stop them from prevailing in the fight against cancer so they can put an end to this horrific disease.


Your support keeps them going. And your generosity brings hope to countless cancer patients and their families. We couldn't do this work without you.

Help us finish the year strong. Support our scientists, Israel's fight against cancer, and our ongoing quest for a cancer-free world.

DONATE NOW

See more of ICRF's achievements over the past 50 years here.

Feature Story: "This is what Burdorfs Do"

The Legacy of Longtime California ICRF Supporters, Jacqueline and Arthur Burdorf

Jacqueline and Arthur Burdorf centered their lives around giving back, and it made a lasting impression on their family who today proudly carries on their legacy. The couple was involved with ICRF's Los Angeles chapter for many years and left a bequest that ensures their impact is felt well into the future.


“Growing up it was understood that this is what Burdorfs do,” recounts their oldest son. “My parents always wanted to be part of the solution, never bystanders. That’s how they wanted to be remembered.”



Read More

Jacqueline and Arthur Burdorf, of blessed memory.

With a planned gift to ICRF, you can make a meaningful impact on countless cancer patients and their loved ones for years to come. To learn more about including ICRF in your estate planning, contact ICRF Senior Director of Development Naomi Smook at naomi.smook@icrfonline.org or 212-969-9800.

Scientist Spotlights

Emily Avitan-Hersh, MD, PhD

ICRF Project Grant Recipient Studying Squamous Cell Carcinoma

Rambam Health Care Campus

Dr. Avitan-Hersh is a leading voice and expert in skin cancer who is growing her lab thanks to ICRF's support. She is director of Dermatology, co-head of the Skin Cancer Surveillance Program, and primary investigator at the Skin Cancer Research Lab at the Clinical Research Institute at Rambam. 


Squamous cell carcinoma is the second most prevalent form of skin cancer, with cases on the rise. More research is needed for better patient outcomes. Dr. Avitan-Hersh chose this underserved area for the opportunity to make a bigger impact on patients. The funding from ICRF is her first substantial cancer research grant.


Read More

Yinon Ben-Neriah, MD, PhD

ICRF Research Professorship Grant Recipient Studying Leukemia

Hebrew University-Hadassah Medical School

Professor Ben-Neriah is grateful to ICRF for awarding him his first-ever cancer research grant, which enabled him to open his lab to study chronic myeloid leukemia (CML), a type of cancer that starts in the bone marrow. His work resulted in discoveries that paved the way for the development of Gleevec, a lifesaving CML treatment.


Prof. Ben-Neriah is an esteemed cancer scientist who received many awards and honors over the course of his fruitful career. With his current ICRF grant, he is working on an experimental drug for acute myeloid leukemia (AML).


Read More

Team ICRF Updates

Upcoming Race - 2025 United Airlines NYC Half Marathon

ICRF is proud to once again be an official charity partner of the iconic United Airlines NYC Half Marathon! Team ICRF will be pounding the pavement across the Big Apple on Sunday, March 16th, 2025, to support ICRF's mission. Help the runners reach their goal of crossing the finish line, as well as their collective goal of raising $25,000 to fight cancer.

Support Team ICRF

Past Race - November 2024 TCS New York City Marathon

Congratulations to our Team ICRF marathon runners who completed this enormous challenge in early November while raising nearly $34,000 and counting for Israel's innovative cancer research.

To learn more about Team ICRF and ways to support our work when embarking on an upcoming race or challenge, contact Ali Blumberg at ali.blumberg@icrfonline.org or 347-389-0712.

Signature Event Highlights

ICRF's signature events brought our communities together to support Israel's fight against cancer. We're grateful to all who attended and supported us!

Chicago: Tower of Hope Gala

This event honored the Anixter and Silva families and had a special tribute to Alpha Epsilon Pi Fraternity. Julie Roth Novack was the evening's guest speaker.

Connecticut: An Evening of Hope

This event honored Jerry Silber, Chair of ICRF's Connecticut chapter and member of the ICRF International Board of Trustees. 

New York: Cocktails for a Cure

Comedian, actor, and writer Judy Gold hosted this event and Jen Goldman, cancer survivor and Team ICRF runner was the evening's guest speaker.

Be on the lookout for more meaningful events in 2025. Check out our calendar here.

Giving Tuesday Reflections

Thank You for Making a Difference on Giving Tuesday

We are grateful to all who participated in our Giving Tuesday match. The collective generosity of our supporters around the world allows us to continue our game-changing work.


We thank our anonymous donor for their generosity in sponsoring the match and for inspiring so many others to support our mission.

News Roundup

Prenatal Blood Test Can Sometimes Hint at Cancer in Moms-to-Be (ABC News) In some instances, a particular blood test during pregnancy called cell-free DNA sequencing can reveal something unexpected — hints of a hidden cancer in the mother.

FDA Approves Treatment for Limited-Stage Small Cell Lung Cancer (Reuters) The FDA approved the blockbuster drug Imfinzi, a human monoclonal antibody that blocks a tumor's ability to evade and dampen the immune system, for patients for whom the disease has not worsened after receiving chemotherapy and radiation.

Pancreatic Cancer Patient Survival Doubled with High Dose of Common Vitamin, Study Finds (FOX News) A trial testing the impact of adding high-dose vitamin C to chemotherapy treatments doubled overall survival rates of patients with late-stage metastatic pancreatic cancer from eight months to 16 months.

Matching Gifts

Help ICRF Fund Twice the Research

Double the impact of your tax-deductible gift to ICRF! Find out if your employer will match your donation.

 

Your gift + your employer's match makes twice as much groundbreaking cancer research possible. Learn more below.

DOUBLE YOUR IMPACT

Gifts of Appreciated Stock

Stocks, bonds, and mutual funds appreciated in value are among the best ways to support ICRF. You may receive a charitable income tax deduction for the full market value of the stock (up to a maximum of 30 percent of your adjusted gross income) and avoid paying the capital gains tax on any increase in the value of the stock.


For more information, contact Executive Director Alan Herman at alan.herman@icrfonline.org or 347-218-5946.

Connect with us on Social Media

See what we're up to and be part of the conversation on social media. Engage with us on Instagram, Facebook, LinkedIn, and X: @ICRFONLINE 

We'd Love to Hear From You

Like what you're reading? Interested in learning more about a particular topic related to Israel's cancer research? We welcome your feedback and ideas for future newsletters and content you'd like to see. Email communications@icrfonline.org and tell us what you think!

DONATE NOW

icrfonline.org

41174338-ba8a-41b9-9bdc-046daab9a7b0 image
DONATE
Facebook  Instagram  LinkedIn  YouTube